December 19, 2024
Federal regulators pulled Eli Lilly's lucrative weight-loss and diabetes drug off the national shortage list Thursday and gave compounding pharmacists two months to stop making copycat versions of the injectable medication, a move with the potential to reignite a Texas legal clash.
October 22, 2024
A federal agency's unusual flip-flop this month on whether to allow copycat versions of a lucrative weight-loss and diabetes drug may cause regulators to move more cautiously as they weigh how to handle future drug shortages.